NRIX
Price
$16.79
Change
+$5.93 (+54.60%)
Updated
Feb 3 closing price
Capitalization
1.73B
69 days until earnings call
Intraday BUY SELL Signals
OCUL
Price
$8.51
Change
-$3.43 (-28.73%)
Updated
Feb 3 closing price
Capitalization
1.81B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs OCUL

Header iconNRIX vs OCUL Comparison
Open Charts NRIX vs OCULBanner chart's image
Nurix Therapeutics
Price$16.79
Change+$5.93 (+54.60%)
Volume$1.25M
Capitalization1.73B
Ocular Therapeutix
Price$8.51
Change-$3.43 (-28.73%)
Volume$6.87M
Capitalization1.81B
NRIX vs OCUL Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. OCUL commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and OCUL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (NRIX: $16.79 vs. OCUL: $8.51)
Brand notoriety: NRIX and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 77% vs. OCUL: 152%
Market capitalization -- NRIX: $1.73B vs. OCUL: $1.81B
NRIX [@Biotechnology] is valued at $1.73B. OCUL’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 3 TA indicator(s) are bullish while OCUL’s TA Score has 4 bullish TA indicator(s).

  • NRIX’s TA Score: 3 bullish, 5 bearish.
  • OCUL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both NRIX and OCUL are a bad buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а -13.50% price change this week, while OCUL (@Biotechnology) price change was -21.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

NRIX is expected to report earnings on Apr 14, 2026.

OCUL is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.81B) and NRIX($1.73B) have the same market capitalization . NRIX YTD gains are higher at: -11.492 vs. OCUL (-29.901). OCUL has higher annual earnings (EBITDA): -233.54M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. OCUL (345M). NRIX has less debt than OCUL: NRIX (56.5M) vs OCUL (77M). NRIX has higher revenues than OCUL: NRIX (83.7M) vs OCUL (55.8M).
NRIXOCULNRIX / OCUL
Capitalization1.73B1.81B95%
EBITDA-248.7M-233.54M106%
Gain YTD-11.492-29.90138%
P/E RatioN/AN/A-
Revenue83.7M55.8M150%
Total Cash429M345M124%
Total Debt56.5M77M73%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXOCUL
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 21 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSEYX14.070.08
+0.57%
Columbia Global Value Inst2
OSCYX23.820.08
+0.34%
Invesco Main Street Small Cap Y
VAAGX27.27-0.03
-0.11%
Virtus NFJ Large-Cap Value R6
WCMOX13.71-0.09
-0.65%
WCM Focused International Opps Ins
PLSAX32.73-0.27
-0.82%
Principal Large Cap S&P 500 Index A

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.76%
KYMR - NRIX
66%
Loosely correlated
+2.12%
DNLI - NRIX
58%
Loosely correlated
-4.22%
IDYA - NRIX
58%
Loosely correlated
+0.50%
SYRE - NRIX
56%
Loosely correlated
+1.65%
XNCR - NRIX
55%
Loosely correlated
-0.99%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with WVE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-6.99%
WVE - OCUL
54%
Loosely correlated
+2.01%
NRIX - OCUL
53%
Loosely correlated
-1.76%
NUVL - OCUL
53%
Loosely correlated
+2.12%
ERAS - OCUL
53%
Loosely correlated
-0.24%
DYN - OCUL
52%
Loosely correlated
+1.07%
More